On ٠٥ نوفمبر ٢٠٢٥, GBIO reported earnings of -0.82 USD per share (EPS) for Q3 25, beating the estimate of -3.23 USD, resulting in a 74.68% surprise. Revenue reached 1.59 مليون, compared to an expected 673.20 ألف, with a 136.78% difference. The market reacted with a -3.28% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -5.00 USD, with revenue projected to reach 442.00 ألف USD, implying an increase of 509.76% EPS, and decrease of -72.27% in Revenue from the last quarter.